Evaluating Combination Immunotherapy for Advanced Cholangiocarcinoma With Pembrolizumab and PEG-Intron
Clinical trial NCT02982720 · TERMINATED
Trial details
- NCT number
- NCT02982720
- Sponsor
- Aiwu Ruth He, MD
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-05
- Primary completion
- 2018-02-09
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.